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Embryonic neuroepithelia and adult subventricular zone (SVZ) stem and progenitor cells express nestin. We characterized a
transgenic line that expresses enhanced green fluorescent protein (eGFP) specified to neural tissue by the second intronic enhancer
of the nestin promoter that had several novel features. During embryogenesis, the dorsal telencephalon contained many and the
ventral telencephalon few eGFP+ cells. eGFP+ cells were found in postnatal and adult neurogenic regions. eGFP+ cells in the
SVZ expressed multiple phenotype markers, glial fibrillary acidic protein, Dlx, and neuroblast-specific molecules suggesting the
transgene is expressed through the lineage. eGFP+ cell numbers increased in the SVZ after cortical injury, suggesting this line
will be useful in probing postinjury neurogenesis. In non-neurogenic regions, eGFP was strongly expressed in oligodendrocyte
progenitors, but not in astrocytes, even when they were reactive. This eGFP+ mouse will facilitate studies of proliferative
neuroepithelia and adult neurogenesis, as well as of parenchymal oligodendrocytes.
1. Introduction
Expression of the intermediate filament protein nestin has
been used as a marker for neural stem and progenitor cells
in the ventricular and subventricular zones [1–3]. Nestin
is also expressed by radial glia [1] which are substrates for
migration and which can give rise to neurons [4, 5]. The
second intronic enhancer of nestin specifies expression of
the gene to neural tissues [6]. We generated a transgenic
mouse using the second intronic enhancer of the nestin
gene and the thymidine kinase minimal promoter to drive
enhanced green fluorescent protein (eGFP+), an approach
similar to what has been successfully used by others (Table 1)
[7–12]. Several useful nestin-Cre mice have also been made
allowing lineage studies and functional studies [13–15];
however for space constraints, we did not include them in
Table 1.
Transgenic reporter mice, even when generated iden-
tically, can have widely divergent expression of the trans-
gene [16]. Indeed, we discovered some aspects of eGFP
expression that differed from previously reported lines. In
our transgenic mouse, eGFP was expressed more robustly
in the pallium than the subpallium during embryogene-
sis. In the adult SVZ, eGFP+ cells expressed markers of
multiple cell subtypes. Interestingly, in the ventral lateral
ventricle, eGFP was primarily expressed by ependymal cells.
Unexpectedly, eGFP was also detected in oligodendrocytes
in the parenchyma throughout development and in the
adult. However, it was not expressed in astrocytes, even after
cortical injuries rendered them reactive. Thus, our novel
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Table 1: Comparison of nestin-reporter mice.
Yamaguchi
et al. [8]
Aoki et al. [7]
Kawaguchi
et al. [9]
Mignone
et al. [12]
Beech
et al. [11]
Our work
Transgenic
strategy
Sequence that
drives transgene
2nd
Intron,
nestin
promoter
2nd Intron,
thymidine
kinase
minimal
promoter (a)
2nd
Intron,
hsp68min
promoter
2nd
Intron,
5.8 kb
nestin
promoter
5.8 kb
upstream
to 5.4 kb
down-
stream of
nestin
Gene (b)
2nd Intron,
thymidine
kinase
promoter
Reporter
molecule
eGFP
β-
galactosidase
eGFP eGFP CREB
Modified
(stable) eGFP
(c)
General
features
Endogenous
nestin
coexpression
n.d Yes Yes (d) Yes n.d. (e) Yes
Brdu+ Yes (f) n.d. (g) Yes (h) Yes Yes Yes
Embryonic
expression
Ventricular zone Yes Yes Yes Yes n.d. Yes
Subventricular
zone
Yes n.d. Yes Yes n.d. Yes
Pallium versus
subpallium
n.d. n.d. n.d. No n.d. Yes
3d ventricle Yes Yes Yes Yes n.d. Yes
Spinal cord Yes Yes Yes n.d. n.d. n.d.
Postmitotic
parencyma
Yes n.d. ? (i) No n.d. Yes
Nonneural tissues No No n.d. No n.d. Yes
Postnasal
and/or adult
expression
light
microscopy
Neurogenic
regions
Yes Yes Yes Yes
Yes-subset
(j)
Yes
Dentate gyrus
progenitors
Yes ? n.d. Yes No Yes
Dentate gyrus
neurons
Yes ? n.d. No No No
SVZ B cells Yes No Yes (k) Yes ? (l) Yes-subset
SVZ C cells n.d. n.d. No (m) n.d. ? Yes-subset
SVZ/RMS A cells Yes n.d. n.d. Yes Yes-subset Yes-subset
Increased in SVZ
after injury
n.d. n.d. n.d. n.d. n.d. Yes
Ependymal cells Yes n.d. Yes Yes ? (l) Yes-subset
OB
Granule
Yes ? n.d. No No Yes
neurons
Periglomerular
Yes ? n.d. Yes Yes-subset Yes
neurons
Accessory OB
n.d. n.d. n.d. n.d. n.d. Yes
neurons
Nonneurogenic
regions
Yes (n) Yes n.d. No Yes (o) Yes
Oligodendro-
cytes
? n.d. n.d. No n.d. Yes
Astrocytes ? No n.d. n.d. n.d. No
Astrocytes after
injury
n.d. No (p) n.d. n.d. n.d. No
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Table 1: Continued.
Yamaguchi
et al. [8]
Aoki et al. [7]
Kawaguchi
et al. [9]
Mignone
et al. [12]
Beech
et al. [11]
Our work
Neurons ? Yes n.d. No n.d. Yes-weak
Nonneural tissue n.d. n.d. n.d. n.d. n.d.
Yes-hair
follicles
Electron
microscopy
SVZ B cells n.d. n.d. n.d. n.d. n.d. Yes
SVZ C cells n.d. n.d. n.d. n.d. n.d. Yes
SVZ A cells n.d. n.d. n.d. n.d. n.d. Yes
Adult ependymal
cells
n.d. n.d. n.d. n.d. n.d. Yes
Oligodendro-
cytes
n.d. n.d. n.d. n.d. n.d. Yes
Cell culture Neurospheres n.d. n.d. Yes (q) Yes n.d. Yes (r)
n.d.: not determined. ?: not clear
(a) Line 3D6—includes mutation of SHP2 tyrosine phosphatase; (b) nestin-tTA mouse crossed with tetracycline regulated CREB used as readout; (c) Okada
et al., 1999; (d) shown in vitro; (e) nestin expressed in the same general areas as transgene, cell coexpression not determined; (f) tested postnatally; (g) BrdU
labeling index not changed, colabelling with transgene not done; (h) embryonically in vivo and in vitro; (i) parenchymal GFP+ cells visible in Figure 1(g); (j)
SVZ but not dentate gyrus; (k) as determined by BrdU retention; (l) S 100b-labelling in Figure 4(a) looks ependymal not astrocytic; (m) determined by lack
of BrdU pulse labelling; (n) glial morphology; (o) not labelled with BrdU; (p) not within 6 hrs post-MCAo; (q) embryonically, self-renewal and multipotency
shown; (r) postnataly, self-renewal and multipotency shown.
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Figure 1: Embryonic proliferative neuroepithelia express eGFP. (a) Transgenic construct. (b) eGFP is expressed at high levels in the VZ
and SVZ at E16. (c) Photomontage of coronal hemisection shows typical bright labelling of proliferative neuroepithelium in the developing
cortex. Scale bar = 250 microns. (d) eGFP labels VZ cells in the third ventricle. Scale bar = 100 microns.
eGFP+ mouse will be useful for studies of neurogenesis as
well as oligodendrocyte genesis.
2. Results
2.1. Embryonic Expression of eGFP in Proliferative Neuroepi-
thelia. Nestin, an intermediate filament protein, is expressed
by neural stem and progenitor cells [3, 9, 17, 18]. We gener-
ated a transgenic mouse that has eGFP [19] specified to neu-
ral tissue by the nestin second intronic enhancer and is driven
by the minimal thymidine kinase promoter (Figure 1(a))
[6]. During embryogenesis, eGFP was found in expected
regions: the large majority of embryonic ventricular zone
and subventricular zone cells were labeled (Figure 1(b)).
The upper layers of the developing cortex contained
eGFP+ processes as well as somata. Unexpectedly, the
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Figure 2: eGFP is expressed in the caudatopallial angle and in the lateral migratory stream at P0. (a) Bright eGFP expression in the
caudatopallial angle (cpa). Overall GFP labelling at P0 has diminished. Scale bar = 250 microns. (b) Two discontinuous populations of
bright eGFP+ cells are found in the CPA (outlined in yellow and white in A, B). Scale bar = 50 microns. (c) The lateral migratory stream
(lms) between the corpus callosum and striatum. Scale bar = 50 microns.
transgene was driven much less robustly in the proliferative
neuroepithelium of the striatum (subpallium) than of the
cerebral cortex (pallium) (Figure 1(c)). GFP+ cells were also
found in the ventricular zone of more caudal regions such as
the third ventricle (Figure 1(d)).
2.2. Postnatal Expression of eGFP in Neurogenic Regions.
At P0, many eGFP+ cells were found in the caudatopallial
angle and lateral migratory stream (Figure 2). These
cells seemed to be distributed in two distinct clusters
(Figure 2(a)). At P14, many eGFP+ cells were found in
the dorsal SVZ (Figure 3(a)), in the rostral migratory
stream, and in the subgranular zone of the dentate gyrus
(not shown). Unexpectedly, eGFP+ cells surrounding the
ventral lateral ventricles were primarily in the ependymal
layer (Figure 3(b)). eGFP+ expression was retained in
the adult SVZ although relatively fewer cells were labeled
(Figure 3(c)). eGFP+ cells in the dorsal SVZ and RMS had
a migratory morphology (Figure 3(d)): oval cell bodies
with a long leading process. eGFP+ cells with migratory,
or adult neuronal morphologies were also found in all
layers of the OB (Figures 3(e)–3(g)) and accessory olfactory
bulb (Figure 4). These results suggested that eGFP labeled
migratory and differentiating SVZ-derived neuroblasts.
Another report of nestin-eGFP mice suggested that
eGFP fluorescence intensity was either dim or bright [12].
In our mice, eGFP fluorescence ranged in a continuum
from barely visible to quite bright (ex. Figure 3(d)). In
order to confirm that we were detecting the transgene and
not exciting anomalous (e.g., paraformaldehyde-induced)
autofluorescence, we immunolabeled with antibodies against
GFP. The anti-GFP immunolabel matched the eGFP signal
(Figure 3(d)).
2.3. Phenotypic Characterization of eGFP Cells in the Postnatal
SVZ. Endogenous nestin has been reported in all three
of the major neural SVZ cells (stem cells, progenitors,
and neuroblasts) [20]. We first sought to characterize
the transgene expression by comparing eGFP fluorescence
with nestin immunohistochemistry. Nestin immunolabeling
revealed the cytoplasm and processes of cells in the SVZ
and ependymal layer (Figures 5(a)–5(c)). Conversely, eGFP
was largely found in the cell body and short processes
(Figures 6(a)–6(b)). For unknown reasons, low levels of
eGFP were also detected with confocal microscopy in the
nucleus of SVZ cells (Figure 6). Close examination showed
many eGFP+ cells that were also labeled by the antinestin
antibody (Figures 5(a)–5(c)). This was similar to other nestin
reporter mice and was therefore expected. We next tested
whether eGFP was coexpressed in the GFAP-expressing cells
of the adult SVZ [21]. GFAP immunolabelling in the SVZ
was fibrous and tangled, similar to nestin (Figure 5(d)). This
made eGFP/GFAP colocalization difficult; however, we did
find rare eGFP+ cells that were GFAP positive (Figure 5(d)).
We hypothesized that some eGFP+ cells in the SVZ would be
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Figure 3: Postnatal and adult neurogenic regions express eGFP. (a) The P14 SVZ is replete with eGFP+ cells. Scale bar = 250 microns. (b)
The majority of eGFP+ cells surounding the ventral lateral ventricle are in the ependymal layer (arrow). Scale bar = 20 microns. (c) eGFP
expression is still robust in the SVZ at P84. Scale bar = 100 microns. (d) Excellent overlap between eGFP fluoresecence and GFP detected
with antibodies (P84 SVZ). Scale bar = 50 microns. (e)–(g) Olfactory bulb labeling. eGFP transgene labels newborn neurons in the granule
(gr) (f) and periglomerular (pgl) (g) layers.
type C progenitor cells [20, 21]. We found eGFP+ cells in the
SVZ that expressed epidermal growth factor receptor, a type
C cell marker (not shown). The transcription factors Dlx and
Mash1 are mostly expressed by SVZ type C progenitors [22,
23], and we found double-labeled cells (Figures 5(e), 5(f)).
We also foundmany eGFP+ cells that expressed doublecortin
(Dcx), a marker of migrating neuroblasts (Figure 5(f)). A
few reports have indicated that nestin may be expressed by
microglial cells [24–26]. We examined whether eGFP+ cells
in the SVZ express the microglial markers CD11b or CD45.
Microglia frequently contacted eGFP+ cells; however we did
not find any double-labeled cells in the SVZ (Figure 5(g).
We next studied the mitotic potential of eGFP+ cells by
administering BrdU for two weeks in four-week-old mice.
eGFP+ cells in the postnatal SVZ and RMS (Figure 7(a))
were labeled with BrdU, indicating that they had been born
during that period. Interestingly, only a small fraction of
BrdU+ cells were eGFP+, suggesting that this transgene only
labels a subset of newly generated cells in the postnatal
SVZ. Neurospheres generated in vitro from proliferative
neuroepithelia can exhibit self-renewal and multipotency,
the two cardinal features of stem cells. We examined the
ability of eGFP+ cells to make neurospheres. Similar to other
nestin-GFP lines [8, 9, 12], the SVZ from these eGFP+
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Figure 4: eGFP is expressed in the accessory olfactory bulb. (a) Schematic showing location of accessory olfactory bulb (AOB). Note that
at this level (caudal OB) the periglomerular layer is only found medially. Boxed area shows location of (b). (b) Low magnification showing
numerous eGFP+ cells in the periglomerular layer and AOB. Boxed areas show locations of (c) and (d). (c), (d) Higher magnification
showing morphology of neurons. P42 mouse.
mice generated many green neurospheres (Figure 7(b)) that
could be passaged multiple times. Since we also found
neurospheres that did not express eGFP, it is likely that some
of the neurospheres formed from eGFP-negative SVZ stem
cells. This was expected since in this line of mice, eGFP is not
found in all SVZ precursor cells. These neurosphere data are
compatible with our phenotypic analysis and suggest that a
portion of eGFP+ cells in the SVZ are stem cells.
2.4. Oligodendrocyte Precursors Express eGFP. eGFP was
also expressed by scattered cells throughout the brain
parenchyma at all ages examined, and were especially
dense in the piriform cortex (Figure 8(a)). Many of these
cells were doublets suggesting that they had recently
divided (Figure 8(b)). Immunoelectron microscopy with
anti-GFP antibodies showed these cells had ultrastruc-
tural features of oligodendrocytes (Figure 8(c)). Previous
work from our laboratory had used EM to delineate SVZ
cells that expressed eGFP. We also found some eGFP+
cells in the parenchyma that expressed the oligodendro-
cyte marker CNPase and which were found as indi-
vidual cells (Figure 8(d)). Most of the CNPase+/eGFP+
cells expressed the transgene at rather low levels. Other
eGFP+ cells scattered throughout the brain were dim
and expressed the neuronal marker NeuN (Figure 8(e)).
The eGFP variant we used is particularly resistant to degra-
dation [19]; therefore, the dim eGFP in neurons may have
retained eGFP. Immunolabelling with anti-GFP antibodies
confirmed the weak neuronal retention of the transgene
(data not shown). We also found bright eGFP+ cells with
processes enveloping NeuN+ cells (Figure 8(e)).
2.5. Reactive Astrocytes Do Not Express eGFP. eGFP was
expressed in oligodendrocyte progenitors; in addition, some
eGFP+ cells in the SVZ were GFAP+. Therefore, we asked
whether eGFPwas expressed in astrocytes outside of the SVZ,
in the parenchyma. We labeled with anti-GFAP antibodies
and did not find any double labeled cells (Figure 9(a)).
Reactive astrocytes have been reported to express nestin
after certain lesion paradigms [24, 27]. To address whether
eGFP+ astrocytes appear after injury, we performed cortical
aspiration lesions (Figure 9(b)). Interestingly, the number of
eGFP+ cells increased in the SVZ at 10 days after injury
(Figure 9(c)). We next performed GFAP immunohistochem-
istry to detect reactive astrocytes. As previously shown
[28], astrocytosis occurred around the lesion, in the corpus
callosum, and in the striatum (Figure 9(d)). In contrast, we
saw no evidence of reactive astrocytosis in the SVZ proper
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Figure 5: Phenotypic identification of eGFP+ cells in the adult SVZ. (a) eGFP+ cells immunolabeled with antinestin antibody; SVZ, P84.
Cells appear to have just gone through cytokinesis. Scale bar = 10 microns. (b) eGFP+ cell immunolabeled with antinestin antibody; SVZ,
P84. Scale bar = 5 microns. (c) Long arrow shows bright, and short arrow dim, eGFP+ cells in the ventral ependymal layer of the lateral
ventricle labeled with antinestin antibody. Scale bar = 10 microns. (d) eGFP+ cell (arrow) expressing GFAP immunoreactivity in the SVZ
of a P28 mouse. Bright cell indicated with arrow has nucleus filled with eGFP and is surrounded by GFAP in extending processes. Other
cells (arrowhead) are in GFAP-negative areas. (e) Some eGFP+ cells coexpress the transcription factor Dlx. Scale bar = 10 microns. (f)
eGFP+ could also be Mash1+. Scale bar = 10 microns. (g) Some eGFP+ cells (arrowheads) coexpress doublecortin in the RMS, whereas
others (arrow) do not. Scale bar = 50 microns. (h) eGFP+ cells in the SVZ (arrow) do not express the microglial marker CD11b+ microglia
(arrowhead). Scale bar = 50 microns.
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Figure 6: Nuclear and cytoplasmic localization of eGFP transgene. (a) and (b) Series of confocal optical sections spaced 1 micron apart,
from P84 SVZ. Four cells are shown. eGFP is found in the nucleus, perinuclear cytoplasm and in processes extending away from the nucleus.
Scale bars = 20 microns.
(though the lesions were close to the SVZ, they did not
extend into it). We quantified eGFP+ cells in the striatum,
corpus callosum, and cerebral cortex in controls (N = 4
mice, 89 cells examined), at 2 days (N = 3, 74 cells), 5
days (N = 4, 100 cells), and 10 days (N = 4, 104 cells)
after injury. We did not find a single eGFP+ cell in these
regions that was colabeled with GFAP (Figure 9(d)). Thus,
whereas eGFP is expressed by some GFAP+ cells in the SVZ,
eGFP is not expressed by astrocytes outside of the SVZ even
when they become reactive after injury. Therefore, use of this
mouse to examine neurogenesis will not be confounded by
the expression of eGFP in reactive astrocytes.
3. Discussion
We have characterized a transgenic mouse in which the
expression of enhanced green fluorescent protein is specified
by the second intronic enhancer of the nestin gene and driven
by the thymidine kinase minimal promoter. eGFP was found
in developmental and adult proliferative neuroepithelia; the
regions within which we expected to find it based on
endogenous nestin expression and other nestin reporter mice
[1, 8, 9, 12]. In the following respects eGFP expression in
this line differed (Table 1) from previously described reporter
lines: it exhibited dorsoventral heterogeneity in neurogenic
regions, and it was expressed by newborn OB neurons and
oligodendrocytes, but was not expressed by astrocytes or
microglia.
eGFP was expressed at higher levels during embryo-
genesis in pallial compared to subpallial proliferative neu-
roepithelia. It may be that other nestin reporter mice also
exhibited dorsoventral differences in eGFP expression, but
were merely not reported. We also found that the dorsal
lateral ganglionic eminence preferentially expressed eGFP at
high levels. This lens-shaped cluster of eGFP+ cells is in
the same location as the Er81+ intermediate domain that
gives rise to a subset of adult SVZ cells [29]. This eGFP+
domain is contiguous with the lateral migratory stream,
which extends from the intermediate domain towards the
basolateral forebrain [30]. Dorsoventral differences were also
found in the adult: dorsal eGFP was primarily expressed in
the SVZ, whereas ventrally, it was primarily expressed in
ependymal cells.
We showed previously that the ventral lateral ventricle in
adult mice is characterized by cells in the SVZ and ependymal
layer that extend long nestin, vimentin, and GFAP-positive
radial glia-like processes into the surrounding neuropil [31].
Interestingly, Dcx+ cells appear to migrate from the ventral
SVZ population amongst the radial glia-like fibers into
the adjacent neuropil [31, 32]. It has been proposed that
ependymal cells lining the lateral ventricles are also stem
cells in this system [33]. Although most labs have not been
able to confirm that ependymal cells normally exhibit stem
cell characteristics [34, 35], the possibility exists that the
identity of the stem cell phenotype varies in subregions of
the ventricular walls. Could it be that the ventral eGFP+
ependyma maintain more stem cell characteristics than
dorsally located ependyma? This transgenic mouse line
should help solve some of these questions.
Some nestin+ cells in vitro exhibit the stem cell charac-
teristics of self-renewal and multipotency [9, 12]. They are
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Figure 7: eGFP+ cells are proliferative and generate neurospheres. (a) The majority of eGFP+ cells in the RMS are positive for BrdU. BrdU
was administered for two weeks daily, and mice sacrificed the last day of BrdU. (b) eGFP+ cells in neurospheres prepared from eGFP+ mice.
mitotically active in vivo and are found at the same locations
and times as brain stem cells [8]. The BrdU and neurosphere
studies we performed showed that many of the eGFP+ cells
were proliferative. In the adult SVZ, a subset of the GFAP+
astrocyte-like cells are thought to be the stem cells [21]. We
found eGFP+ cells that expressed GFAP, both in vivo and in
vitro. We used electron microscopy to quantify the percent of
SVZ cells expressing eGFP in a previous study [36].We found
that 8% of the eGFP+ cells in the SVZ were astrocyte-like
cells, 18% were ependymal cells, 8% were transit amplifying
type C cells, and 63% were neuroblasts. It is not clear if these
“downstream” cells in the SVZ lineage merely inherited and
retained this particularly bright variant of eGFP [19], or if
the transgene was actively driven. Either way, in previous
studies we showed that the eGFP+ neuroblasts are useful
for studying migration [36, 37]. In contrast to [12], we did
not notice any correlation between eGFP+ brightness and
progression from precursor cells in the SVZ to differentiated
cell in the OB. Mignone and colleagues showed that SVZ
stem/progenitor cells were GFP-bright whereas neuroblasts
were dim. In our line SVZ progenitor cells, and migratory
neuroblasts as well as OB neurons exhibited bright eGFP+.
The most parsimonious explanation for this discrepancy is
that we used a particularly stable variant of eGFP [19].
In the current study it was of particular interest that both
periglomerluar and granule neurons, the final product of the
SVZ system were eGFP+. This is in contrast with reports by
other groups, in which only periglomerular neurons were
labeled [11, 12]. Periglomerular cells are a small subset of
cells generated by the SVZ; therefore, it is curious that
the reporter molecules in the previous reports were only
expressed in these neurons [11, 12]. Although we do not
know for certain, it is likely that eGFP labeling of granule
and periglomerular neurons is due to retention of the eGFP,
since nestin mRNA is not detected in these cells. Nestin
as a cytoskeletal protein may have a different half-life than
GFP. We do not advocate use of this line as a nestin lineage
tracer but point out that since it labels multiple OB neurons,
it could be useful for their study. Taken together, the data
suggest that the mice described here will be useful for
visualizing all types of SVZ cells and multiple OB neurons.
However, in these mice eGFP is not a specific marker of stem
cells but is also found in postmitoitc cells and tissues.
A low level of oligodendrocyte genesis occurs homeo-
statically in the adult. We found eGFP+ cells scattered in
the neural parenchyma that were morphologically similar
to oligodendrocytes. They were often found in pairs, which
may have been due to recent divisions. Some of these eGFP+
cells expressed CNPase, an oligodendrocyte marker. This is
consistent with others finding that another oligodendrocyte
marker NG2, [38] and PDGFRα were expressed by nestin+
cells [39]. Since the eGFP fluorescence was bright in these
parenchymal cells, they are suitable for live imaging studies
of oligodendrocyte dynamics.
In addition to oligodendrocytes, astrocytes andmicroglia
may have expressed eGFP [24–27]. However, we found
that neither cell type expressed eGFP. Reactive astrocytes
are notorious for “aberrantly” expressing nonastrocytic
molecules. However, we found that after cortical aspira-
tion lesions, eGFP was not expressed in astrocytes, sim-
ilar to what others have found [40]. Interestingly these
lesions did result in larger numbers of eGFP+ cells in
the SVZ, suggesting that the line can be used to monitor
SVZ plasticity in response to injury, but that astrocyte
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Figure 8: Oligondendrocyte progenitors express eGFP. (a) P14 piriform cortex contains multiple bright eGFP+ cells with the morphology
of oligodendrocyte progenitor cells (OPC). Note the numerous pairs of cells. Scale bar = 50 microns. (b) Two eGFP+ cells showing typical
morphology of OPC’s. (P28 mouse, near base of lateral ventricles). Scale bar = 20 microns. (c) eGFP+ immunoreactive cell with the
ultrastructural features of an oligodendrocyte. Scale bar = 2 microns. (d) eGFP+ striatal cell that is immunolabeled with the oligodendrocyte
marker CNPase (P28 mouse). CNPase antibodies also labeled white matter tracts like the corticostriate fiber tract (ft) seen in this panel. Scale
bar = 10 microns. (e) Oligodendrocyte-like eGFP+ cell (arrowhead) does not express NeuN. This cell wraps processes around an adjacent
NeuN+ neuron. Note that a few NeuN+ neurons (arrow) exhibit weak eGFP fluorescence. Scale bar = 20 microns.
expression of the transgene will not be a confounding
factor.
One possible explanation for the differences in the var-
ious nestin-reporter mice is background strain differences.
For example C57BL/6 mice were used in the study Mignone
et al. [12], whereas we used FVB/N’s. Another difference
is that we relied on the nestin second intronic enhancer
followed by the thymidine kinase minimal promoter to
drive eGFP, whereas Mignone and colleagues engineered
GFP in between the nestin promoter and the nestin second
intronic enhancer. In fact, there are several important
differences between our nestin reporter mice and others
arguing that nestin promoter/enhancer driven transgenes
may be vulnerable to positional effects. Although outside the
scope of this study careful comparison of integration sites
may be revelatory in the future.
Although this eGFP+ mouse exhibits substantial sim-
ilarities to other nestin reporter animals, it also exhibits
several differences that may be informative biologically and
useful technically. The expression in adult ependymal cells
suggests that some ependymal cells may indeed be stem cells.
Expression of eGFP+ cells in postmitotic brain parenchyma
will allow further investigation of these cells.
4. Experimental Procedures
4.1. eGFP Transgenic Mice. Standard molecular biology
techniques were used to generate the transgenic constructs.
Briefly, the second intron from the rat nestin gene [6, 41] was
placed upstream of the thymidine kinase minimal promoter
to drive a modifed form of enhanced green fluorescent
protein (EGFPmut4) [19]. DNA was generously provided
by the following individuals: nestin/tk, J. M. Hebert, EGF-
Pmut4, A. Okada. Transgenic mice in the FVB/N strain
were generated by pronuclear injection, in the transgenic
mouse cores at Children’s Hospital Boston and Brigham and
Women’s Hospital. Animals were genotyped by PCR of tail
DNA using primers specific to transgene sequences. Two
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Figure 9: Parenchymal astrocytes do not express eGFP. (a) GFAP+ astrocytes are not constitutively labeled with eGFP transgene (P84
striatum). Scale bar = 20 microns. (b) Cortical lesions (les) were performed to determine if reactive astrocytes express eGFP. Coronal section
adapted from Paxinos’ atlas (Paxinos and Franklin, 2001). (c) The number of eGFP+ cells in the SVZ increased 10 days after injury (∗∗P <
.01, t-Test). (d) eGFP+ cells in the denervated striatum did not colabel with GFAP immunohistochemistry (reactive astrocytes 10 days after
injury).
mm of tail was placed into a 1.5mL microfuge tube with
200 μL 1x PBND buffer (Jackson Labs) and 1 μL of 10mg/mL
Proteinase K and incubated at 55◦C, overnight, and 1-2μL
of the processed, lysed tail DNA was used for each PCR
reaction.
4.2. Cortical Lesions. Were performed as described previ-
ously [42–44]. Adult mice were anesthetized with a mixture
of ketamine (100mg/kg) and xylazine (10mg/kg) IP, placed
in a Cunningham stereotax mouse adapter (Stoelting). The
left frontoparietal cerebral cortex from Bregma to 1.2mm
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anterior to Bregma was gently aspirated with a fire-polished
glass Pasteur pipette attached to a vacuum, to the level of
the corpus callosum. Gelfoam was placed in the lesion before
suturing. Nonlesioned control mice were anesthetized with
ketamine/xylaxine and housed with lesioned animals.
4.3. BrdU Administration. Brdu (200mg/kg) was injected
intraperitoneally in 4-week-old eGFP+ mice every 12 hrs for
two weeks.
4.4. Tissue Preparation. Male and female eGFP+ mice rang-
ing between ages E16-P224 were used: E16 N = 4, P0 N =
3, P14 N = 4, P28 N = 1, P30 N = 3, P63 N = 1,
P84 N = 4, and P224 N = 1. Mice were anesthetized
at 4◦C with wet ice between E162-P14. Ages P28–P224
were anesthetized with sodium pentobarbital and perfused
with 4% paraformaldehyde in 0.1M sodium phosphate
buffered saline (PBS), pH 7.6. Thirty micron free-floating
coronal sections were cut on a sliding microtome and
stored in cryoprotectant at −20◦C. All animal procedures
were in accordance with NIH animal care guidelines and
were approved by the Children’s Memorial Hospital IACUC
committee.
4.5. Neurosphere Production. The lateral wall of the lateral
ventricle, including the SVZ, was dissected from coro-
nal slices of P5 mouse brains, dissociated with 200mL
Papain (4U/mL; Worthington), and plated at a density
of 3,000 cells/mL in 25 cm2 flasks coated with Poly-HEME
(2.4mg/cm2; Sigma) in Neurobasal (Invitrogen) supple-
mented with the growth factors fibroblast growth factor
(FGF-2) (20 ng/mL; Sigma) and epidermal growth factor
(EGF) (20 ng/mL; R&D Systems), as well as B-27 Supplement
(Gibco), N-2 Supplement (Gibco), L-glutamine (2mM;
Invitrogen), and Penicillin/Streptomycin (100U/mL; Gibco).
Neurospheres were dissociated and passaged 9 days after
seeding. Cultures were kept for at least 4 passages.
4.6. Immunohistochemistry. The following antibodies were
used: anti-2′,3′-cyclic nucleotide 3′-phosphodiesterase
(myelin CNPase; mouse monoclonal, 1 : 1000, Sternberger
Monoclonals Inc., Lutherville, MD), antipan Dlx [45] (rabbit
polyclonal, 1 : 50, a gift from Dr. J. D. Kohtz, Northwestern
Univ.), antidoublecortin (Dcx, goat polyclonal, 1 : 100;
Santa Cruz Biotech, Santa Cruz, CA), antiepidermal growth
factor receptor (EGFr, mouse monoclonal, 1 : 50; Sigma, St.
Louis, MO), antiglial fibrillary acidic protein (GFAP, rabbit
polyclonal, 1 : 250; DAKO, Carpinteria, CA), antinestin
(mouse monoclonal, 1 : 100; Chemicon, Temecula, CA),
antineuronal nuclei (NeuN, mouse monoclonal, 1 : 1000;
Chemicon, Temecula, CA), anti-CD45 (rat monoclonal,
1 : 500; Chemicon, Temecula, CA), antibromodeoxyuridine
(BrdU, Sheep polyclonal, 1 : 500, Becton Dickinson, San
Jose, CA), and antigreen fluorescent protein (GFP, rabbit
polyclonal, 1 : 500; Gibco, Calsbad, CA). Sections were
blocked with 50mM glycine in phosphate buffered saline
(PBS) to reduce autofluorescence of paraformaldehyde-fixed
tissue. Sections were washed, blocked in PBS containing
0–0.1% Triton X-100 and 10% Donkey Serum, DS (Sigma,
St. Louis, MO), incubated overnight at 4◦C in primary
antibody, washed and exposed to 1 : 400 Cy3-conjugate
secondary antibodies (Molecular Probes, Eugene, OR) for
one hr at RT, washed twice, rinsed in phosphate buffer
(PB), mounted on slides, and coverslipped. For BrdU
immunohistochemistry, sections were washed in DNAse
buffer with 0.5% Triton X-100 for 20 minutes and then
incubted w/DNAse 2mg/mL with 0.5% Trition X-100.
Nuclei were stained by applying 40mg/mL 4′,6-Diamidi-
no-2-phenylindole dihydrochloride (hydrate) (DAPI, Sigma,
St. Louis, MO) for 10min before the final rinses. Negative
controls omitting the primary antibodies were carried out in
all experiments for all the secondary antibodies used. Sec-
tions were analyzed with Leica epifluorescent microscopes
controled by Openlab software (Improvision, Cambridge
MA) or an Olympus Confocal microscope controlled by Flu-
oview software (Olympus, Melville, NY). All GFP+ cells were
imaged with 40x or 63x objectives and by shifting between
the GFP, Cy3, and DAPI filter cubes. Images generated with
these systems were assembled in Adobe Photoshop.
4.7. Electron Microscopy. Mice were perfused with 2%
paraformaldehyde and 0.1% glutaraldehyde in PBS and left
in same fixative overnight at 4◦C (N = 1 mouse, P45).
The brain was vibratome sectioned at 50 μm and washed
in PBS, 6x, 10min. Aldehydes were blocked by 30min
incubation in 50mM glycine in PBS. Sections were washed
in PBS 3 × 10min, incubated in 5% normal goat serum,
0.1% triton-x 100 in PBS (PBS+), and rabbit anti-GFP
1 : 1000 added for overnight incubation at 4◦C. Sections were
washed in PBS, 3x, 10min, incubated for 60min, RT, in
antirabbit conjugated 1.4 nm gold (Nanoprobes, Yaphank,
NY) in PBS+. Sections were washed in PBS, 3x, 10min,
PB, 3x, 10min, DH2O, 3x, 10min, then incubated in Gold
Enhance solution (Nanoprobes) for 5min, washed in DH2O,
3x, 5min, PB 3x, 5min, fixed in 1% gluteraldehyde for
30min, washed in PBS, fixed in 1% osmium tetroxide in PBS
for 10min, washed in PBS, dehydrated in EtOH, infiltrated
in 1 : 1 propylene oxide : epon for 1 hr at RT, 1 : 2 PO : epon
for 2 hrs, epon for 2 hrs, and embedded in epon overnight
at 60◦C. Stained ultrathin sections in 2% aqueous uranyl
acetate for 10min, washed in DH2O, and viewed on a JEOL
electron microscope equipped with a digital camera.
Abbreviations
3d V: Third ventricle
cc: Corpus callosum
CNPase: 2′,3′-cyclic nucleotide 3′-phosphodiesterase
cpa: Caudatopallial angle
ctx: Cerebral cortex
Dcx: Doublecortin
E: Embryonic age
eGFP: Enhanced green fluorescent protein
epl: External plexiform layer (olfactory bulb)
ft: Fiber tract
ge: Ganglionic eminence
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GFAP: Glial fibrillary acidic protein
gl: Glomerular layer (olfactory bulb)
gr: Granule layer (of olfactory bulb)
LGE: Lateral ganglionic eminence
lms: Lateral migratory stream
lv: Lateral ventricle
OB: Olfactory bulb
OPC: Oligodendrocyte progenitor cell
P: Postnatal age
pA: Polyadenylation
pgl: Periglomerular layer (of olfactory bulb)
RMS: Rostral migratory stream
Spt: Septum
Str: Striatum
SVZ: Subventricular zone
TK: Thymidine kinase
VZ: Ventricular zone.
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